← Leaderboards
Laurent Coscoy
University Of California Berkeley
$5,535,775
Attributed
$7,009,375
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $769.3K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,009,375 · 8
By mechanism
R01$5,390,038 · 3
R21$1,386,701 · 4
R56$232,636 · 1
Top collaborators
- Ellen A Robey7 shared
Most similar at University Of California Berkeley
Same institution · by research overlap
- Ellen A Robey$26,169,163
- Nilabh Shastri$19,407,030
- Nir Yosef$1,077,843
- Aaron Streets$5,818,704
- Penelope M Drake$133,668
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionViralResponseProteinsVaccinesVirusCellsImmunoregulationPathogenSignal TransductionImmuneT-LymphocyteHuman Herpesvirus 8Immune ResponseLymphoproliferative DisordersPathogenesisKaposi SarcomaMediatingVirus DiseasesAntiviral ResponseIn VivoAffinityReceptorCharacteristics
Grant awards (25)
Presentation of Qa-1 restricted peptides during homeostasis and viral infection$574,805
R01 · FY2024 · AI
Roles of Calprotectin in a mouse model of maternal immune activation$194,500
R21 · FY2024 · HD · contact PI
Presentation of Qa-1 restricted peptides during homeostasis and viral infection$574,805
R01 · FY2023 · AI
Presentation of Qa-1 restricted peptides during homeostasis and viral infection$574,805
R01 · FY2022 · AI
Presentation of Qa-1 restricted peptides during homeostasis and viral infection$31,419
R01 · FY2022 · AI
Presentation of Qa-1 restricted peptides during homeostasis and viral infection$573,548
R01 · FY2021 · AI
Presentation of Qa-1 restricted peptides during homeostasis and viral infection$49,720
R01 · FY2021 · AI
Presentation of Qa-1 restricted peptides during homeostasis and viral infection$568,098
R01 · FY2020 · AI
Immune Modulation by Gammaherpesviruses$234,200
R01 · FY2016 · CA · contact PI
Immune Modulation by Gammaherpesviruses$257,242
R01 · FY2015 · CA · contact PI
Immune Modulation by Gammaherpesviruses$250,356
R01 · FY2014 · CA · contact PI
Immune Modulation by Gammaherpesviruses$243,962
R01 · FY2013 · CA · contact PI
Title: Role of Heparan sulfate in B-cell responses$164,966
R21 · FY2013 · AI · contact PI
Immune Modulation by Gammaherpesviruses$259,318
R01 · FY2012 · CA · contact PI
Title: Role of Heparan sulfate in B-cell responses$215,359
R21 · FY2012 · AI · contact PI
Gammaherpesvirus pathogenesis: role of heparan sulfate in vivo$181,031
R21 · FY2011 · AI · contact PI
Gammaherpesvirus pathogenesis: role of heparan sulfate in vivo$222,054
R21 · FY2010 · AI · contact PI
Defining TLR9 regulatory sequences in natural DNA; implication for vaccine develo$184,005
R21 · FY2010 · AI · contact PI
Immune Evasion by KSHV$232,636
R56 · FY2009 · CA · contact PI
Defining TLR9 regulatory sequences in natural DNA; implication for vaccine develo$224,786
R21 · FY2009 · AI · contact PI
Immune evasion by KSHV$232,411
R01 · FY2008 · CA · contact PI
Immune evasion by KSHV$232,763
R01 · FY2007 · CA · contact PI
Immune evasion by KSHV$240,046
R01 · FY2006 · CA · contact PI
Immune evasion by KSHV$246,128
R01 · FY2005 · CA
Immune evasion by KSHV$246,412
R01 · FY2004 · CA